Advertisement
Home 2016

Archives

Taking antibiotics at a very young age could increase the risk of certain allergic conditions later in life

Early Exposure to Antibiotics Ups Risk of Allergic Dz Later in Life

0
Researchers found higher risk for hay fever, eczema in those exposed to antibiotics before age 2
Benralizumab

Benralizumab Effective Treatment for Severe, Uncontrolled Asthma

0
Benralizumab significantly reduces exacerbations, two trials show
Patients with are at an increased risk of failing simulated driving tests

Compromised Driving Skills Seen in Patients With Sleep Apnea

0
Lane position deviation significantly worse in patients with obstructive sleep apnea
For patients with asthma

Review Finds Vitamin D Beneficial for Patients With Asthma

0
Reduction in rate of exacerbations requiring systemic corticosteroids or requiring ER/hospital visit
For patients with ST-segment elevation myocardial infarction

Off-Hours Presentation Not Detrimental in STEMI

0
Time of PCI did not affect STEMI efficacy or safety outcomes in large international trial
Investigation of suspected coronary heart disease with cardiovascular magnetic resonance-guided care is superior to National Institute for Health and Care Excellence guidelines-directed care and does not differ significantly from myocardial perfusion scintigraphy-guided care

Imaging Strategies Reduce Unnecessary Angiography

0
CMR is better for reducing unnecessary angiography compared with NICE guideline-directed care
For patients with peripheral arterial disease

Ischemic Events Down With Prolonged DAPT in PAD

0
Lower risk of ischemic events seen for patients with peripheral arterial disease undergoing PCI
Drug-eluting stents may perform no better for patients over the long-term

Survival, QOL, CV Event Rate No Better With Drug-Eluting Stents

0
But, the drug-eluting devices do lead to fewer repeat revascularizations
Survivors of myocardial infarction live longer now than they did before

Invasive Interventions Improving Survival in NSTEMI Patients

0
Improvement in all-cause mortality tied to angiography, PCI, and CABG procedures
For acute major bleeding within 18 hours after factor Xa inhibitor administration

Andexanet Bolus, Infusion Cuts Anti-Factor Xa Activity

0
Findings in patients with acute major bleeding associated with factor Xa inhibitors